Liquidia (NASDAQ:LQDA) Receives “Buy” Rating from Needham & Company LLC

Liquidia (NASDAQ:LQDA)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $19.00 target price on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 85.00% from the company’s current price.

A number of other research analysts also recently issued reports on the stock. HC Wainwright dropped their target price on shares of Liquidia from $32.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, August 20th. Scotiabank initiated coverage on shares of Liquidia in a report on Wednesday, October 16th. They set a “sector outperform” rating and a $30.00 price objective on the stock. Lifesci Capital assumed coverage on Liquidia in a research note on Thursday, October 3rd. They issued an “outperform” rating and a $30.00 target price for the company. BTIG Research dropped their price target on Liquidia from $29.00 to $25.00 and set a “buy” rating on the stock in a research note on Monday, August 19th. Finally, Bank of America cut their price target on Liquidia from $24.00 to $23.00 and set a “buy” rating on the stock in a report on Tuesday, August 20th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, six have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $24.00.

Liquidia Stock Performance

Shares of NASDAQ LQDA opened at $10.27 on Thursday. The company has a market capitalization of $788.63 million, a P/E ratio of -6.54 and a beta of 0.21. Liquidia has a 52-week low of $6.10 and a 52-week high of $16.99. The company’s 50 day moving average price is $10.48 and its 200-day moving average price is $11.52.

Insider Activity

In related news, insider Rajeev Saggar sold 2,526 shares of the stock in a transaction on Friday, October 18th. The stock was sold at an average price of $11.19, for a total value of $28,265.94. Following the completion of the sale, the insider now directly owns 204,857 shares of the company’s stock, valued at approximately $2,292,349.83. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Liquidia news, insider Rajeev Saggar sold 2,526 shares of the stock in a transaction dated Friday, October 18th. The shares were sold at an average price of $11.19, for a total value of $28,265.94. Following the completion of the sale, the insider now owns 204,857 shares in the company, valued at approximately $2,292,349.83. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Caligan Partners Lp bought 150,000 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was acquired at an average price of $9.51 per share, for a total transaction of $1,426,500.00. Following the purchase, the director now directly owns 6,994,997 shares in the company, valued at approximately $66,522,421.47. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold 21,551 shares of company stock worth $236,021 over the last 90 days. 30.10% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Whitcomb & Hess Inc. boosted its holdings in shares of Liquidia by 10.2% in the 3rd quarter. Whitcomb & Hess Inc. now owns 11,599 shares of the company’s stock worth $116,000 after buying an additional 1,074 shares during the last quarter. American International Group Inc. boosted its stake in Liquidia by 5.2% in the first quarter. American International Group Inc. now owns 24,806 shares of the company’s stock valued at $366,000 after acquiring an additional 1,215 shares during the last quarter. Arizona State Retirement System boosted its stake in Liquidia by 10.7% in the second quarter. Arizona State Retirement System now owns 13,842 shares of the company’s stock valued at $166,000 after acquiring an additional 1,341 shares during the last quarter. Bleakley Financial Group LLC grew its position in shares of Liquidia by 6.6% during the 1st quarter. Bleakley Financial Group LLC now owns 33,250 shares of the company’s stock valued at $490,000 after acquiring an additional 2,057 shares during the period. Finally, Quest Partners LLC purchased a new stake in shares of Liquidia during the 2nd quarter worth approximately $27,000. Institutional investors own 64.54% of the company’s stock.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).